Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss and network over 40 presentations and case studies focusing on the key issues in inhalation and respiratory drug delivery.

2 Interactive Streams:

  • Development & Formulation of Inhaled Therapies
  • Inhalation Devices & Analytics

See Agenda with speakers & presentations

Meet thought-leaders working in Inhalation & Respiratory Drug Delivery:

Advances in developing an inhaled therapy:

In vitro and in vivo performance of inhaled therapies and regulatory pathways by Frank Thielmann, Novartis and Simon Hiskett, Mylan

Device commercialisation:

Challenges in device commercialisation and design of experiments in analytical development by James Kraunsoe, AstraZeneca and Holger Memmesheimer, Boehringer Ingelheim

New trends in product design:

Rational design for construction of antibiotic dry powder inhalers by Francesca Buttini, University of Parma and Valerie Fenster, Amgen

Webinar: Download For Free Today

Stratification and Considerations for DPI Development

Speaker: Sven Stegemann, Professor, Graz University of Technology